• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替莫唑胺作为膀胱副神经节瘤的新辅助治疗

Temozolomide as neoadjuvant therapy for bladder paraganglioma.

作者信息

Liu Yi, Jia Congwei, Wang Zhan, Zhang Yushi

机构信息

Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Endocrine. 2025 May;88(2):431-433. doi: 10.1007/s12020-025-04174-2. Epub 2025 Feb 7.

DOI:10.1007/s12020-025-04174-2
PMID:39920550
Abstract

Bladder Paraganglioma (BPG) is a rare form of pheochromocytoma and paraganglioma (PPGL) characterized by elevated blood pressure when urinating, headache, dizziness, palpitations, and hematuria. Surgical resection is the most commonly used treatment for BPG. Here, we reporte a man who initially presented with hypogastralgia and hematuria and was diagnosed as BPG at local hospital. The size of mass was too huge to receive partial cystectomy at diagnosis. Then this patient was referred to our medical center. After evaluation, we chose temozolomide as neoadjuvant therapy to reduce the tumor size. Followed by seven cycles of temozolomide, the tumor was decreased and was successfully removed via partial cystectomy.

摘要

膀胱副神经节瘤(BPG)是嗜铬细胞瘤和副神经节瘤(PPGL)的一种罕见形式,其特征为排尿时血压升高、头痛、头晕、心悸和血尿。手术切除是BPG最常用的治疗方法。在此,我们报告一名男性患者,最初表现为下腹痛和血尿,在当地医院被诊断为BPG。诊断时肿块太大,无法进行部分膀胱切除术。然后该患者被转诊至我们的医疗中心。经过评估,我们选择替莫唑胺作为新辅助治疗以缩小肿瘤大小。在进行七个周期的替莫唑胺治疗后,肿瘤缩小,通过部分膀胱切除术成功切除。

相似文献

1
Temozolomide as neoadjuvant therapy for bladder paraganglioma.替莫唑胺作为膀胱副神经节瘤的新辅助治疗
Endocrine. 2025 May;88(2):431-433. doi: 10.1007/s12020-025-04174-2. Epub 2025 Feb 7.
2
Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma-Case Report and Review of the Literature.替莫唑胺是转移性嗜铬细胞瘤/副神经节瘤患者的潜在治疗工具——病例报告及文献复习。
Front Endocrinol (Lausanne). 2020 Feb 18;11:61. doi: 10.3389/fendo.2020.00061. eCollection 2020.
3
[Cystoscopy-assisted partial cystectomy for paraganglioma of the urinary bladder].膀胱嗜铬细胞瘤的膀胱镜辅助下膀胱部分切除术
Hinyokika Kiyo. 2008 Sep;54(9):611-4.
4
Bladder paraganglioma treated with open partial cystectomy: a case report.经开放性部分膀胱切除术治疗的膀胱副神经节瘤:一例报告。
J Med Case Rep. 2022 Dec 25;16(1):479. doi: 10.1186/s13256-022-03715-x.
5
[Paraganglioma of the bladder : two case reports].[膀胱副神经节瘤:两例报告]
Hinyokika Kiyo. 2014 Nov;60(11):561-6.
6
[Bladder paraganglioma. Apropos of a case].[膀胱副神经节瘤。附病例报告]
Arch Esp Urol. 1990 May;43(4):405-7.
7
Unrecognised adrenergic symptoms and the delayed diagnosis of urinary bladder paraganglioma.未被识别的肾上腺素能症状与膀胱副神经节瘤的延迟诊断。
Vojnosanit Pregl. 2015 Sep;72(9):831-6. doi: 10.2298/vsp140409060d.
8
Paraganglioma of the Urinary Bladder: A Series of 22 Cases in a Single Center.膀胱副神经节瘤:单中心 22 例系列报告。
Clin Genitourin Cancer. 2017 Oct;15(5):e765-e771. doi: 10.1016/j.clgc.2017.03.010. Epub 2017 Mar 28.
9
Partial Cystectomy of Paraganglioma of the Urinary Bladder Before Living Kidney Transplantation: Case Report.活体肾移植前膀胱副神经节瘤部分膀胱切除术:病例报告
Transplant Proc. 2018 Apr;50(3):898-901. doi: 10.1016/j.transproceed.2018.01.015.
10
[A case of paraganglioma of the urinary bladder].[一例膀胱副神经节瘤]
Hinyokika Kiyo. 1983 Mar;29(3):333-7.

本文引用的文献

1
Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results From a Multicenter Study. presentation,Management,and Outcomes of Urinary Bladder Paraganglioma: Results From a Multicenter Study
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2811-2821. doi: 10.1210/clinem/dgac427.
2
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma.SDHx 突变与替莫唑胺在恶性嗜铬细胞瘤和副神经节瘤中的应用。
Endocr Relat Cancer. 2022 Jul 19;29(9):533-544. doi: 10.1530/ERC-21-0392. Print 2022 Sep 1.
3
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
阐明替莫唑胺耐药性在神经胶质瘤中的机制及克服耐药性的策略。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188616. doi: 10.1016/j.bbcan.2021.188616. Epub 2021 Aug 20.
4
Metastatic Pheochromocytomas and Abdominal Paragangliomas.转移性嗜铬细胞瘤和腹部副神经节瘤
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e1937-e1952. doi: 10.1210/clinem/dgaa982.
5
Temozolomide in the Era of Precision Medicine.精准医学时代的替莫唑胺
Cancer Res. 2017 Feb 15;77(4):823-826. doi: 10.1158/0008-5472.CAN-16-2983. Epub 2017 Feb 3.
6
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.SDHB突变与转移性嗜铬细胞瘤或副神经节瘤患者对替莫唑胺的反应相关。
Int J Cancer. 2014 Dec 1;135(11):2711-20. doi: 10.1002/ijc.28913. Epub 2014 May 5.
7
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).扩展方案、递增剂量替莫唑胺与达卡巴嗪治疗 IV 期黑色素瘤:一项随机 III 期研究(EORTC 18032)的最终结果。
Eur J Cancer. 2011 Jul;47(10):1476-83. doi: 10.1016/j.ejca.2011.04.030. Epub 2011 May 18.
8
Role of temozolomide in pediatric brain tumors.替莫唑胺在儿童脑肿瘤中的作用。
Childs Nerv Syst. 2006 Jul;22(7):652-61. doi: 10.1007/s00381-006-0081-z. Epub 2006 Mar 25.